Infertility remedy world news group gas oil ratio units

##

Doctors told the St. Louis, Mo., couple that their only hope for biological children was in vitro fertilization (IVF), a process they opposed as Catholics. The Yeungs began to pursue adoption, but still wanted answers about their infertility.

Patrick, who is now an OB-GYN and fertility specialist, learned about an IVF alternative called “NaProTechnology,” short for “natural procreative technology,” also referred to as “restorative reproductive medicine.” Catholic doctor Thomas Hilgers founded the method in the mid-1980s after the Vatican denounced artificial insemination and the creation of test-tube babies. It relies on meticulous tracking of a woman’s menstrual cycle, diagnostics, and treatments that address the underlying causes of infertility. The treatments range from supplements and hormonal therapy to surgery to restore female reproductive organs impeded by abnormal growths, blocked fallopian tubes, or ovarian dysfunction.

One in 8 couples has trouble achieving and sustaining pregnancy, and 12 percent of U.S. women under the age of 45 have sought fertility treatment, according to the Centers for Disease Control and Prevention. In a booming fertility industry dominated by IVF services, doctors often push infertile couples toward assisted reproductive technology as their only option for biological children.

Sometimes this leaves the cause of infertility unexplained and untreated. It can also leave couples hopeless if, like the Yeungs, they opt out of IVF for religious and ethical reasons. Many couples have become concerned about IVF practices, including the freezing of surplus embryos, selective reduction, and screening procedures that weed out “abnormal” embryos. One clinic in Fort Worth, Texas, promotes NaProTechnology as a “morally acceptable system which maintains the integrity of the person.”

But others are drawn to NaProTechnology simply because IVF is invasive and expensive: The average cost of an IVF cycle (often not covered by health insurance) is $12,000, with only about 30 percent of women giving birth to a healthy baby with just one round. In contrast, NaProTechnology often leads to a “billable diagnosis” of a medical condition likely covered by insurance, Patrick says.

Looking for answers, Dorothy began charting her female cycle and had an exploratory surgery to find out why she couldn’t conceive. A laparoscopy revealed she had severe endometriosis, one of the top three causes of female infertility. After surgical treatment, doctors showed Dorothy her “obliterated ovaries” and she “cried for weeks,” believing her chances for biological children were gone. That same year, the Yeungs adopted a baby girl.

But the Yeungs were shocked six months later when Dorothy found she was pregnant. They’ve since had three children naturally. Patrick, a “restorative fertility” specialist at Saint Louis University, shares their story with his patients: “You can’t guarantee a baby. … But we can set the table and see what happens.”

Over 65 percent of couples who use NaProTechnology achieve pregnancy within two years, according to a study conducted by Hilgers’ Pope Paul VI Institute for the Study of Human Reproduction in Omaha, Neb. Another study, published in the Journal of the American Board of Family Medicine in 2008, found that over 50 percent of infertile couples had a child after two years of following NaProTechnology protocol.

These success rates, along with fertility tracking apps and the popularization of holistic medicine, are pushing NaProTechnology beyond its Catholic roots. Doctors who now provide NaProTechnology have affiliations with public universities, Mayo Clinic, and a U.S. Navy hospital. In 2015, Poland’s national healthcare system cut IVF funding in favor of NaProTechnology. Hilgers’ network of over 300 FertilityCare centers has expanded to 10 countries on five continents in the last decade.

Still, the wider medical field has been slow to accept NaProTechnology. In 2015, the American College of Obstetricians and Gynecologists acknowledged the method in a patient pamphlet about “fertility awareness-based methods,” but the group does not advocate aggressively operating on endometriosis, a standard NaProTechnology practice.

Some doctors are reluctant to recommend NaProTechnology for women with a diminishing biological clock. Live birth rates for both IVF and NaProTechnology drop significantly for female patients over age 35. While a typical IVF cycle takes three months, some NaProTechnology patients spend years undergoing treatment. “While you are waiting for this to kick in, you’ve lost years off the biological clock, which is a high price to pay,” Dr. Richard Paulson of the University of Southern California Keck School of Medicine told Mother Jones.

These fears are real, and some NaProTechnology doctors worry that couples desperate for babies will ignore the medical conditions causing their infertility. Women with endometriosis, for example, wait an average of seven years for a diagnosis, according to the National Institutes of Health. “IVF often bypasses infertility problems in the production of a child,” said Canadian physician Tracey Parnell, the communications and development director at the London-based International Institute for Restorative Reproductive Medicine. “The focus has become very narrow. We’ve stopped looking for the root causes of infertility.”